By Mill Chart
Last update: Dec 15, 2023
Discover PFIZER INC (NYSE:PFE)—a stock that our stock screener has recognized as a solid dividend pick with strong fundamentals. NYSE:PFE showcases decent financial health and profitability while providing a sustainable dividend. We'll explore the specifics further.
ChartMill provides a Dividend Rating for every stock, ranging from 0 to 10. This rating assesses various dividend aspects, including yield, growth, and sustainability. NYSE:PFE earns a 7 out of 10:
ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NYSE:PFE has earned a 6 out of 10:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:PFE, the assigned 8 is a significant indicator of profitability:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
For an up to date full fundamental analysis you can check the fundamental report of PFE
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
PFIZER INC
NYSE:PFE (4/22/2024, 10:14:08 AM)
26.345
+0.34 (+1.33%)
Biotech stocks are having a relatively strong year as investors focus on the growing M&A in the healthcare space. Johnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO organization. Pfizer acquired Seagen in 2023 while Merck bought Harpoon Therapeutics. So, here are some of the top biotech stocks to […]
A little up-front investment can go a long way with these three stocks.
Pfizer, Biogen and Wolfspeed are making fresh appearances on the NYSE new lows list as the general stock sell-off continues.
Thursday's session: most active stock in the S&P500 index
The answer to that question will either make you wince or smile.
Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media.
Paul Schatz avoids hot stocks while seeing opportunities in bonds and off-the-radar stocks.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.